These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19204914)

  • 1. Non-motor cognitive-perceptual dysfunction associated with drug-induced parkinsonism.
    Kim JH; Byun HJ
    Hum Psychopharmacol; 2009 Mar; 24(2):129-33. PubMed ID: 19204914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective cognitive dysfunction associated with drug-induced parkinsonism in schizophrenia.
    Kim JH; Kim SY; Byun HJ
    Parkinsonism Relat Disord; 2008; 14(3):239-42. PubMed ID: 17851106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
    Kim JH; Byun HJ
    J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive dysfunction in drug induced parkinsonism (DIP).
    Kim YD; Kim JS; Chung SW; Song IU; Yang DW; Hong YJ; Kim YI; Ahn KJ; Kim HT; Lee KS
    Arch Gerontol Geriatr; 2011; 53(2):e222-6. PubMed ID: 21163539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective cognitive dysfunction in first-episode and chronic schizophrenic patients.
    Moritz S; Lambert M; Andresen B; Böthern A; Naber D; Krausz M
    Compr Psychiatry; 2001; 42(3):213-6. PubMed ID: 11349240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of adverse drug effects with subjective well-being in patients with schizophrenia receiving stable doses of risperidone.
    Kim JH; Kim MJ
    Clin Neuropharmacol; 2009; 32(5):250-3. PubMed ID: 19620847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research.
    Knol W; Keijsers CJ; Jansen PA; van Marum RJ
    J Clin Psychopharmacol; 2010 Feb; 30(1):57-63. PubMed ID: 20075649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of motor dexterity in schizophrenia assessed by a novel finger movement test.
    Midorikawa A; Hashimoto R; Noguchi H; Saitoh O; Kunugi H; Nakamura K
    Psychiatry Res; 2008 Jun; 159(3):281-9. PubMed ID: 18448171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism.
    Caligiuri MP; Teulings HL; Filoteo JV; Song D; Lohr JB
    Hum Mov Sci; 2006 Oct; 25(4-5):510-22. PubMed ID: 16647772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship between emotional distress, cognitive performance and health - related quality of life in patients with hepatitis C prior to antiviral treatment].
    Rothenhäusler HB; Scherr M; Putz-Bankuti C; Kapper A; Stepan A; Baranyi A; Haas-Krammer A; Haas B; Stauber R
    Fortschr Neurol Psychiatr; 2009 Aug; 77(8):457-63. PubMed ID: 19676008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellar and other neurological soft signs in antipsychotic-naïve schizophrenia.
    Varambally S; Venkatasubramanian G; Thirthalli J; Janakiramaiah N; Gangadhar BN
    Acta Psychiatr Scand; 2006 Nov; 114(5):352-6. PubMed ID: 17022795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
    Moritz S; Krausz M; Gottwalz E; Andresen B
    Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia.
    Fervaha G; Agid O; Takeuchi H; Lee J; Foussias G; Zakzanis KK; Graff-Guerrero A; Remington G
    Schizophr Res; 2015 Feb; 161(2-3):351-6. PubMed ID: 25471015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
    Piskulić D; Olver JS; Maruff P; Norman TR
    Hum Psychopharmacol; 2009 Aug; 24(6):437-46. PubMed ID: 19637398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.
    Bebbington PE; Angermeyer M; Azorin JM; Marwaha S; Marteau F; Toumi M
    Acta Psychiatr Scand Suppl; 2009; (438):22-8. PubMed ID: 19132963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin-associated adverse cognitive effects: survey results from 171 patients.
    Evans MA; Golomb BA
    Pharmacotherapy; 2009 Jul; 29(7):800-11. PubMed ID: 19558254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished neurocardiac dynamics associated with antipsychotic-induced extrapyramidal syndrome.
    Kim JH; Yi SH; Park KT; Ahn YM; Lee KY; Yang SA; Kim YS
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):459-63. PubMed ID: 16343860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics.
    Munhoz RP; Werneck LC; Teive HA
    Clin Neurol Neurosurg; 2010 Jun; 112(5):431-5. PubMed ID: 20347518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.